Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Noyes, E. Corona, J. Zwanziger, W. Hall, Hongwei Zhao, Hongkun Wang, A. Moss, A. Dick (2007)
Health-Related Quality of Life Consequences of Implantable Cardioverter Defibrillators: Results From MADIT IIMedical Care, 45
A. Buxton, Kerry Lee, J. Fisher, M. Josephson, E. Prystowsky, G. Hafley (1999)
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.The New England journal of medicine, 341 25
W. Kannel, P. Wilson, R. D’Agostino, J. Cobb (1998)
Sudden coronary death in women.American heart journal, 136 2
AB Curtis (2004)
Prevention of sudden cardiac death: when is a woman just like a man?, 15
S. Yusuf, R. Garg, D. Zucker (1991)
Analyses by the Intention‐to‐Treat Principle in Randomized Trials and DatabasesPacing and Clinical Electrophysiology, 14
R. Makkar, B. Fromm, R. Steinman, M. Meissner, M. Lehmann (1993)
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugsJAMA, 270
R. Dersimonian, R. Dersimonian, N. Laird, N. Laird (1986)
Meta-analysis in clinical trials.Controlled clinical trials, 7 3
A. Schaechter, A. Kadish (2003)
DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE).Cardiac electrophysiology review, 7 4
W. Zareba, A. Moss, W. Hall, David Wilber, J. Ruskin, S. McNitt, M. Brown, Hongyue Wang, Madit-Ii Investigators (2005)
Clinical Course and Implantable Cardioverter Defibrillator Therapy in Postinfarction Women with Severe Left Ventricular DysfunctionJournal of Cardiovascular Electrophysiology, 16
Heart Disease and Stroke — 2008 Update Ata - Glance statistics
W. Stumpf, M. Sar, G. Aumüller (1977)
The heart: a target organ for estradiol.Science, 196 4287
AJ Moss, WJ Hall, DS Cannom (1996)
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia., 335
A. Russo, N. Stamato, M. Lehmann, G. Hafley, Kerry Lee, K. Pieper, A. Buxton (2004)
Influence of Gender on Arrhythmia Characteristics and Outcome in the Multicenter UnSustained Tachycardia TrialJournal of Cardiovascular Electrophysiology, 15
D. Moher, A. Jadad, Graham Nichol, Marie Penman, P. Tugwell, Sharon Walsh (1995)
Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists.Controlled clinical trials, 16 1
PJ Kudenchuk, GH Bardy, JE Poole (1997)
Malignant sustained ventricular tachyarrhythmias in women: characteristics and outcome of treatment with an implantable cardioverter/defibrillator., 8
Adrian Hernandez, G. Fonarow, L. Liang, S. Al‐Khatib, L. Curtis, K. Labresh, C. Yancy, N. Albert, E. Peterson (2007)
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure.JAMA, 298 13
A. Moss, W. Hall, D. Cannom, J. Daubert, Steven Higgins, Helmut Klein, Joseph Levine, Sanjeev Saksena, Albert Waldo, David Wilber, Mary Brown, Moonseong Heo (1996)
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.The New England journal of medicine, 335 26
S. Strickberger, J. Hummel, T. Bartlett, H. Frumin, C. Schuger, S. Beau, Cynthia Bitar, F. Morady (2003)
Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT.Journal of the American College of Cardiology, 41 10
Akshay Desai, J. Fang, W. Maisel, K. Baughman (2004)
Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-analysis of Randomized Controlled TrialsJAMA, 292
M. Nakagawa, T. Ooie, Baiqing Ou, M. Ichinose, N. Takahashi, M. Hara, H. Yonemochi, T. Saikawa (2005)
Gender Differences in Autonomic Modulation of Ventricular Repolarization in HumansJournal of Cardiovascular Electrophysiology, 16
AE Buxton, KL Lee, JD Fisher, ME Josephson, EN Prystowsky, G Hafley (1999)
A randomized study of the prevention of sudden death in patients with coronary artery disease., 341
R. Lampert, C. Mcpherson, J. Clancy, T. Caulin–Glaser, L. Rosenfeld, W. Batsford (2004)
Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators.Journal of the American College of Cardiology, 43 12
R. Haynes, N. Wilczynski, K. McKibbon, Cynthia Walker, J. Sinclair (1994)
Developing optimal search strategies for detecting clinically sound studies in MEDLINE.Journal of the American Medical Informatics Association : JAMIA, 1 6
Shao-kui Wei, J. McCurley, Stephen Hanlon, M. Haigney (2007)
Gender Differences in Na/Ca Exchanger Current and β‐Adrenergic Responsiveness in Heart Failure in Pig MyocytesAnnals of the New York Academy of Sciences, 1099
G. Bardy, Kerry Lee, D. Mark, J. Poole, D. Packer, R. Boineau, M. Domanski, C. Troutman, Jill Anderson, G. Johnson, S. McNulty, N. Clapp-Channing, L. Davidson-Ray, Elizabeth Fraulo, D. Fishbein, R. Luceri, J. Ip (2005)
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.The New England journal of medicine, 352 3
P. Kudenchuk, G. Bardy, J. Poole, G. Dolack, M. Gleva, Ramu Reddy, G. Jones, C. Troutman, Jill Anderson, George Johnson (1997)
Malignant Sustained Ventricular Tachyarrhythmias in Women:Journal of Cardiovascular Electrophysiology, 8
Rajesh Dash, Konrad Frank, Andrew Carr, C. Moravec, E. Kranias (2001)
Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium.Journal of molecular and cellular cardiology, 33 7
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008].
A. Moss, W. Zareba, W. Hall, H. Klein, D. Wilber, D. Cannom, J. Daubert, S. Higgins, Mary Brown, M. Andrews (2002)
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.The New England journal of medicine, 346 12
R. Redberg (2007)
Disparities in use of implantable cardioverter-defibrillators: moving beyond process measures to outcomes data.JAMA, 298 13
Xiao-Ke Liu, A. Katchman, M. Drici, Steven Ebert, Ivan Ducic, Martin Morad, Raymond Woosley (1998)
Gender difference in the cycle length-dependent QT and potassium currents in rabbits.The Journal of pharmacology and experimental therapeutics, 285 2
J. Higgins, S. Thompson (2002)
Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 21
Bigger Jt (1997)
Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgeryThe New England Journal of Medicine, 337
A. Curtis (2004)
Prevention of Sudden Cardiac Death:Journal of Cardiovascular Electrophysiology, 15
D. Mark, C. Nelson, K. Anstrom, S. Al‐Khatib, A. Tsiatis, P. Cowper, N. Clapp-Channing, L. Davidson-Ray, J. Poole, G. Johnson, Jill Anderson, Kerry Lee, G. Bardy (2006)
Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart Failure: Results From the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Circulation, 114
S. Hohnloser, K. Kuck, P. Dorian, R. Roberts, J. Hampton, R. Hatala, E. Fain, M. Gent, S. Connolly (2004)
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.The New England journal of medicine, 351 24
C. Begg, Madhuchhanda Mazumdar (1994)
Operating characteristics of a rank correlation test for publication bias.Biometrics, 50 4
V. Vizgirda, G. Wahler, Korie Sondgeroth, M. Ziolo, D. Schwertz (2002)
Mechanisms of sex differences in rat cardiac myocyte response to beta-adrenergic stimulation.American journal of physiology. Heart and circulatory physiology, 282 1
A. Kadish, A. Dyer, J. Daubert, R. Quigg, N. Estes, Kelley Anderson, H. Calkins, D. Hoch, J. Goldberger, A. Shalaby, William Sanders, A. Schaechter, Joseph Levine (2004)
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.The New England journal of medicine, 350 21
D. Cook, G. Guyatt, G. Ryan, J. Clifton, L. Buckingham, A. Willan, William Mcllroy, A. Oxman (1993)
Should unpublished data be included in meta-analyses? Current convictions and controversies.JAMA, 269 21
D. Lloyd‐Jones, M. Larson, E. Leip, A. Beiser, R. D'Agostino, W. Kannel, J. Murabito, R. Vasan, E. Benjamin, D. Levy (2002)
Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart StudyCirculation: Journal of the American Heart Association, 106
D. Moher, P. Fortin, A. Jadad, P. Jüni, T. Klassen, J. Lorier, A. Liberati, A. Penna, K. Linde (1996)
Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviewsThe Lancet, 347
M. Hara, P. Danilo, M. Rosen (1998)
Effects of gonadal steroids on ventricular repolarization and on the response to E4031.The Journal of pharmacology and experimental therapeutics, 285 3
Yi‐Jen Chen, S-H Lee, M. Hsieh, CHIEN‐JU Hsiao, Wen-Chung Yu, C. Chiou, Shih-Ann Chen (1999)
Effects of 17β‐Estradiol on Tachycardia‐Induced Changes of Atrial Refractoriness and Cisapride‐Induced Ventricular ArrhythmiaJournal of Cardiovascular Electrophysiology, 10
Min-Cheol Song, G. Helguera, M. Eghbali, N. Zhu, M. Zarei, R. Olcese, L. Toro, E. Stefani (2001)
Remodeling of Kv4.3 Potassium Channel Gene Expression under the Control of Sex Hormones*The Journal of Biological Chemistry, 276
C. Albert, R. Quigg, S. Saba, N. Estes, Andi Shaechter, H. Subacius, Adam Howard, J. Levine, A. Kadish (2008)
Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy.American heart journal, 156 2
D. Bänsch, M. Antz, S. Boczor, M. Volkmer, J. Tebbenjohanns, K. Seidl, M. Block, F. Gietzen, J. Berger, K. Kuck (2002)
Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy: The Cardiomyopathy Trial (CAT)Circulation: Journal of the American Heart Association, 105
Camille Frazier, K. Alexander, L. Newby, S. Anderson, E. Iverson, M. Packer, J. Cohn, S. Goldstein, P. Douglas (2007)
Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials.Journal of the American College of Cardiology, 49 13
J. Zwanziger, W. Hall, A. Dick, Hongwei Zhao, A. Mushlin, R. Hahn, Hongkun Wang, M. Andrews, C. Mooney, Hongyue Wang, A. Moss (2006)
The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.Journal of the American College of Cardiology, 47 11
A. Russo, J. Poole, D. Mark, Jill Anderson, A. Hellkamp, Kerry Lee, G. Johnson, M. Domanski, G. Bardy (2008)
Primary Prevention with Defibrillator Therapy in Women: Results from the Sudden Cardiac Death in Heart Failure TrialJournal of Cardiovascular Electrophysiology, 19
L. Curtis, S. Al‐Khatib, A. Shea, B. Hammill, Adrian Hernandez, K. Schulman (2007)
Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death.JAMA, 298 13
M. Haigney, W. Zareba, Javed Nasir, S. McNitt, Douglas McAdams, Philip Gentlesk, R. Goldstein, A. Moss (2009)
Gender differences and risk of ventricular tachycardia or ventricular fibrillation.Heart rhythm, 6 2
ORIGINAL INVESTIGATION Effectiveness of Implantable Cardioverter- Defibrillators for the Primary Prevention of Sudden Cardiac Death in Women With Advanced Heart Failure A Meta-analysis of Randomized Controlled Trials Hamid Ghanbari, MD; Ghassan Dalloul, MD; Reema Hasan, MD; Marcos Daccarett, MD, MSc; Souheil Saba, MD; Shukri David, MD; Christian Machado, MD Background: Numerous clinical trials have estab- failure that reported all-cause mortality as an outcome lished a role for implantable cardioverter-defibrillators for the female population. Of the 2619 reports identi- in the prevention of sudden cardiac death in patients with fied, 5 trials that enroll 934 women were included in the heart failure. However, questions remain that regard the meta-analysis. clinical benefit of these therapies in different patient sub- groups. Specifically, the role of implantable cardioverter- Results: Pooled data from the 5 trials revealed no sta- defibrillators in women with heart failure for the pri- tistically significant decrease in all-cause mortality in mary prevention of sudden cardiac death has not been women with heart failure who receive implantable car- well established. Our objective is to determine whether dioverter-defibrillators (hazard ratio, 1.01; 95% confi- implantable cardioverter-defibrillators reduce mortality dence interval, 0.76-1.33). in women with advanced heart failure. Conclusions: Implantable cardioverter-defibrillator Methods: We
JAMA Internal Medicine – American Medical Association
Published: Sep 14, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.